Uncategorized

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) – April 11, 2023

Mirum Pharmaceuticals, Inc. announced that on April 10, 2023, the Compensation Committee of Mirum’s Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 25,950 shares of common stock and 12,960 restricted stock units to five new employees under Mirum’s 2020 Inducement Plan.

Mirum Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) – April 11, 2023 Read More »

CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) – April 11, 2023

CTI BioPharma Corp. announced that an authorized subcommittee of the Compensation Committee of its Board of Directors granted equity awards to two new employees as equity inducement awards outside of the Company’s Amended and Restated 2017 Equity Incentive Plan and material to the employees’ acceptance of employment with the company.

CTI BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) – April 11, 2023 Read More »

Scroll to Top